Company intelligence / Profile preview

Rockfield Medical Devices

Ownership: Private
Development stage: Commercial

Overview

The company's lead product, the Mobility+ Enteral Feeding System, received FDA 510(k) clearance in November 2022 for use in users aged two years and older. It delivers liquid nutrition formula through an enteral access device without gravity or electronics. Initial limited market release began late 2022 with full US launch anticipated Q1–Q2 of following year. No clinical trial data required as it’s a medical device cleared via equivalence pathway.

Therapeutic areas: Gastroenterology
Modalities: DeviceMechanical pump (for enteral feeding)Elastomeric enteral feeding system
Industry: Therapeutic Medical Devices

Partnerships

U Deliver Medical (US sales/distribution partnership announced June 2025)

Beyond the preview

Go deeper on Rockfield Medical Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rockfield Medical Devices.

Explore the full profile